Brief: Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
23/06/2025 12:16
June 23 (Reuters) - Illumina Inc ILMN.O: ILLUMINA TO ACQUIRE SOMALOGIC, ACCELERATING ITS PROTEOMICS BUSINESS AND ADVANCING THE COMPANY'S MULTIOMICS STRATEGY ILLUMINA INC - TO BUY SOMALOGIC FOR $350 MILLION PLUS $75 MILLION IN MILESTONES ILLUMINA INC - EXPECTS SOMALOGIC BUSINESS TO BE PROFITABLE IN 2027 Source text: ID:nPnbcNwfxa Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07